Pharmaceutical science to improve the human condition
Douglas Braaten, David Alvaro, Azra Jaferi · 2013
Where to buy
Amazon’s price changes daily, so the most accurate place to see it is there, at the moment you buy.
View on AmazonAbout the book
"This Annals volume presents the scientific achievements by winners and finalists of the 2012 Prix Galien USA. Contributions include scholarly summaries from biopharmaceutical industry leaders (GlaxoSmithKline, MethylGene, Bristol-Myers Squibb, Novartis, Optimer Pharmaceuticals, Janssen, Bayer, Merck, UCB Pharma, Medtronic, and Novocure) on pharmaceutical advances in the treatment of a wide range of diseases including advanced melanoma, C. difficile-associated diarrhea, partial-onset seizures, chronic hepatitis C infection, recurrent glioblastoma, and thrombosis-mediated conditions, as well as advances in transcatheter valve technology and ventricular assist devices"--
Book details
- Year
- 2013
- Language
- English
- Series
- Annals of the New York Academy of Sciences -- volume 1291
- Publisher
- Wiley Periodicals Inc. on behalf of the New York Academy of Sciences
- Editions
- 1
- Pages
- 105
- ISBN
- 9781573319164
Data source: Wikidata
More by Douglas Braaten
